Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 365

1.

Dietary n-3 PUFA May Attenuate Experimental Colitis.

Charpentier C, Chan R, Salameh E, Mbodji K, Ueno A, Coëffier M, Guérin C, Ghosh S, Savoye G, Marion-Letellier R.

Mediators Inflamm. 2018 Feb 15;2018:8430614. doi: 10.1155/2018/8430614. eCollection 2018.

2.

Alterations in Docosahexaenoic Acid-Related Lipid Cascades in Inflammatory Bowel Disease Model Mice.

Nishiumi S, Izumi Y, Yoshida M.

Dig Dis Sci. 2018 Jun;63(6):1485-1496. doi: 10.1007/s10620-018-5025-4. Epub 2018 Mar 21.

PMID:
29564669
3.

Nutritional Interventions in the Patient with Inflammatory Bowel Disease.

Limketkai BN, Wolf A, Parian AM.

Gastroenterol Clin North Am. 2018 Mar;47(1):155-177. doi: 10.1016/j.gtc.2017.09.007. Epub 2017 Dec 7. Review.

PMID:
29413010
4.

Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.

Scaioli E, Sartini A, Bellanova M, Campieri M, Festi D, Bazzoli F, Belluzzi A.

Clin Gastroenterol Hepatol. 2018 Jan 31. pii: S1542-3565(18)30106-X. doi: 10.1016/j.cgh.2018.01.036. [Epub ahead of print]

PMID:
29391271
5.

RvD1 inhibits TNFα-induced c-Myc expression in normal intestinal epithelial cells and destabilizes hyper-expressed c-Myc in colon cancer cells.

Zhong X, Lee HN, Surh YJ.

Biochem Biophys Res Commun. 2018 Feb 5;496(2):316-323. doi: 10.1016/j.bbrc.2017.12.171. Epub 2018 Jan 3.

PMID:
29305860
6.

Impact of Omega-3 Fatty Acids on the Gut Microbiota.

Costantini L, Molinari R, Farinon B, Merendino N.

Int J Mol Sci. 2017 Dec 7;18(12). pii: E2645. doi: 10.3390/ijms18122645. Review.

7.

The Imbalance between n-6/n-3 Polyunsaturated Fatty Acids and Inflammatory Bowel Disease: A Comprehensive Review and Future Therapeutic Perspectives.

Scaioli E, Liverani E, Belluzzi A.

Int J Mol Sci. 2017 Dec 5;18(12). pii: E2619. doi: 10.3390/ijms18122619. Review.

8.

GPR120: Mechanism of action, role and potential for medical applications.

Karakuła-Juchnowicz H, Róg J, Juchnowicz D, Morylowska-Topolska J.

Postepy Hig Med Dosw (Online). 2017 Nov 19;71(0):942-953. doi: 10.5604/01.3001.0010.5809. Review.

9.

Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases.

Ungaro F, Rubbino F, Danese S, D'Alessio S.

Front Immunol. 2017 Oct 23;8:1331. doi: 10.3389/fimmu.2017.01331. eCollection 2017. Review.

10.

Dietary n‑3 polyunsaturated fatty acids ameliorate Crohn's disease in rats by modulating the expression of PPAR‑γ/NFAT.

Yao J, Lu Y, Zhi M, Hu P, Wu W, Gao X.

Mol Med Rep. 2017 Dec;16(6):8315-8322. doi: 10.3892/mmr.2017.7673. Epub 2017 Sep 29.

PMID:
28990050
11.

[Nutrition and dietary supplement in chronic inflammatory bowel diesease].

Hvas CL, Borre M, Fassov JL.

Ugeskr Laeger. 2017 Jul 31;179(31). pii: V12160870. Danish.

PMID:
28869011
12.

MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice.

Ungaro F, Tacconi C, Massimino L, Corsetto PA, Correale C, Fonteyne P, Piontini A, Garzarelli V, Calcaterra F, Della Bella S, Spinelli A, Carvello M, Rizzo AM, Vetrano S, Petti L, Fiorino G, Furfaro F, Mavilio D, Maddipati KR, Malesci A, Peyrin-Biroulet L, D'Alessio S, Danese S.

Gastroenterology. 2017 Nov;153(5):1363-1377.e6. doi: 10.1053/j.gastro.2017.07.048. Epub 2017 Aug 4.

13.

Analysis of endogenous lipids during intestinal wound healing.

Lee Y, Choo J, Kim SJ, Heo G, Pothoulakis C, Kim YH, Im E.

PLoS One. 2017 Aug 11;12(8):e0183028. doi: 10.1371/journal.pone.0183028. eCollection 2017.

14.

Docosahexaenoyl serotonin emerges as most potent inhibitor of IL-17 and CCL-20 released by blood mononuclear cells from a series of N-acyl serotonins identified in human intestinal tissue.

Wang Y, Balvers MGJ, Hendriks HFJ, Wilpshaar T, van Heek T, Witkamp RF, Meijerink J.

Biochim Biophys Acta. 2017 Sep;1862(9):823-831. doi: 10.1016/j.bbalip.2017.05.008. Epub 2017 May 16.

PMID:
28526351
15.

Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection.

Gobbetti T, Dalli J, Colas RA, Federici Canova D, Aursnes M, Bonnet D, Alric L, Vergnolle N, Deraison C, Hansen TV, Serhan CN, Perretti M.

Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3963-3968. doi: 10.1073/pnas.1617290114. Epub 2017 Mar 29.

16.

Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.

Khan I, Samson SE, Grover AK.

Med Princ Pract. 2017;26(3):201-217. doi: 10.1159/000468988. Epub 2017 Mar 8.

17.

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis.

Vargas Robles H, Castro Ochoa KF, Nava P, Silva Olivares A, Shibayama M, Schnoor M.

J Vis Exp. 2017 Jan 5;(119). doi: 10.3791/55095.

PMID:
28117803
18.

BCFA suppresses LPS induced IL-8 mRNA expression in human intestinal epithelial cells.

Yan Y, Wang Z, Greenwald J, Kothapalli KS, Park HG, Liu R, Mendralla E, Lawrence P, Wang X, Brenna JT.

Prostaglandins Leukot Essent Fatty Acids. 2017 Jan;116:27-31. doi: 10.1016/j.plefa.2016.12.001. Epub 2016 Dec 5.

PMID:
28088291
19.

Anti-inflammatory effects of an oxylipin-containing lyophilised biomass from a microalga in a murine recurrent colitis model.

Ávila-Román J, Talero E, Rodríguez-Luna A, García-Mauriño S, Motilva V.

Br J Nutr. 2016 Dec;116(12):2044-2052. doi: 10.1017/S0007114516004189. Epub 2016 Dec 27.

PMID:
28025954
20.

Supplemental Content

Loading ...
Support Center